增强抗球孢子菌病疫苗免疫力的新策略。 - Suppr

Novel strategies to enhance vaccine immunity against coccidioidomycosis.

作者信息

Cole Garry T, Hung Chiung-Yu, Sanderson Sam D, Hurtgen Brady J, Wüthrich Marcel, Klein Bruce S, Deepe George S, Ostroff Gary R, Levitz Stuart M

机构信息

Department of Biology and South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, San Antonio, Texas, United States of America.

Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.

出版信息

PLoS Pathog. 2013;9(12):e1003768. doi: 10.1371/journal.ppat.1003768. Epub 2013 Dec 19.

DOI:10.1371/journal.ppat.1003768

PMID:24367252

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3868515/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d9/3868515/0776ded90308/ppat.1003768.g001.jpg

相似文献

Novel strategies to enhance vaccine immunity against coccidioidomycosis.

PLoS Pathog. 2013;9(12):e1003768. doi: 10.1371/journal.ppat.1003768. Epub 2013 Dec 19.

A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.

Infect Immun. 2009 Aug;77(8):3196-208. doi: 10.1128/IAI.00459-09. Epub 2009 Jun 1.

Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.

Vaccine. 2018 May 31;36(23):3375-3380. doi: 10.1016/j.vaccine.2018.04.026. Epub 2018 Apr 30.

A vaccine against coccidioidomycosis is justified and attainable.

Med Mycol. 2004 Jun;42(3):189-216. doi: 10.1080/13693780410001687349.

Protective immunity in coccidioidomycosis.

Res Immunol. 1998 May-Jun;149(4-5):417-28; discussion 506-7. doi: 10.1016/s0923-2494(98)80765-7.

Development of vaccines for coccidioidomycosis.

Mycopathol Mycol Appl. 1970;41(1):177-85. doi: 10.1007/BF02051493.

An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.

Vaccine. 2012 Jun 29;30(31):4681-90. doi: 10.1016/j.vaccine.2012.04.084. Epub 2012 May 8.

Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.

Vaccine. 2016 Oct 17;34(44):5336-5343. doi: 10.1016/j.vaccine.2016.08.078. Epub 2016 Sep 9.

Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.

Infect Immun. 2007 Dec;75(12):5777-87. doi: 10.1128/IAI.00807-07. Epub 2007 Sep 17.

Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.

Methods Mol Biol. 2017;1625:45-64. doi: 10.1007/978-1-4939-7104-6_4.

引用本文的文献

Understanding yeast shells: structure, properties and applications.

ADMET DMPK. 2024 Feb 15;12(2):299-317. doi: 10.5599/admet.2118. eCollection 2024.

A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species of .

Vaccines (Basel). 2024 Jan 9;12(1):67. doi: 10.3390/vaccines12010067.

Comparative Genomics of and Prediction of New Vaccines and Drug Targets.

J Fungi (Basel). 2023 Feb 2;9(2):193. doi: 10.3390/jof9020193.

Mouse Model of a Human STAT4 Point Mutation That Predisposes to Disseminated Coccidiomycosis.

Immunohorizons. 2022 Feb 11;6(2):130-143. doi: 10.4049/immunohorizons.2200007.

Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development.

Curr Trop Med Rep. 2019 Sep 15;6(3):132-144. doi: 10.1007/s40475-019-00184-z. Epub 2019 Jun 14.

Immunological Aspects of Diagnosis and Management of Childhood Tuberculosis.

Infect Drug Resist. 2021 Mar 8;14:929-946. doi: 10.2147/IDR.S295798. eCollection 2021.

CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against Infection.

J Immunol. 2020 Jun 15;204(12):3296-3306. doi: 10.4049/jimmunol.1900793. Epub 2020 May 1.

Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.

ACS Infect Dis. 2020 May 8;6(5):1169-1181. doi: 10.1021/acsinfecdis.0c00005. Epub 2020 Apr 13.

Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.

Clin Ther. 2019 Oct;41(10):1939-1954.e1. doi: 10.1016/j.clinthera.2019.08.011. Epub 2019 Oct 22.

The Rise of : Forces Against the Dust Devil Unleashed.

Front Immunol. 2019 Sep 11;10:2188. doi: 10.3389/fimmu.2019.02188. eCollection 2019.

本文引用的文献

Progress Toward a Human Vaccine Against Coccidioidomycosis.

Curr Fungal Infect Rep. 2012 Dec 1;6(4):235-244. doi: 10.1007/s12281-012-0105-y.

Extracellular ammonia at sites of pulmonary infection with Coccidioides posadasii contributes to severity of the respiratory disease.

Microb Pathog. 2013 Jun-Jul;59-60:19-28. doi: 10.1016/j.micpath.2013.04.003. Epub 2013 Apr 10.

Increase in reported coccidioidomycosis--United States, 1998-2011.

MMWR Morb Mortal Wkly Rep. 2013 Mar 29;62(12):217-21.

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.

Lancet. 2013 Mar 23;381(9871):1021-8. doi: 10.1016/S0140-6736(13)60177-4.

Coccidioidomycosis acquired in Washington State.

Clin Infect Dis. 2013 Mar;56(6):847-50. doi: 10.1093/cid/cis1028. Epub 2012 Dec 7.

Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.

Infect Immun. 2012 Nov;80(11):3960-74. doi: 10.1128/IAI.00566-12. Epub 2012 Sep 4.

Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells.

PLoS Pathog. 2012;8(7):e1002771. doi: 10.1371/journal.ppat.1002771. Epub 2012 Jul 19.

An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.

Vaccine. 2012 Jun 29;30(31):4681-90. doi: 10.1016/j.vaccine.2012.04.084. Epub 2012 May 8.

Vaccines for the twenty-first century society.

Nat Rev Immunol. 2011 Nov 4;11(12):865-72. doi: 10.1038/nri3085.

Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).

Infect Immun. 2011 Nov;79(11):4511-22. doi: 10.1128/IAI.05726-11. Epub 2011 Aug 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Novel strategies to enhance vaccine immunity against coccidioidomycosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献